Alercell

A word from the founder

Watch Video

Fighting
Cancer early!

Early detection is key to increasing cure rates and reducing mortality.

Lena S1 Test

LENA Q51®

Alercell is committed to revolutionizing early detection through advanced DNA sequencing techniques. By identifying cancer at its earliest stages, Alercell aims to assist patients in achieving better outcomes, potentially even preventing the progression of the disease entirely.

Service

Our Diagnostics

Our approach enables a deeper understanding of how genetic

alterations contribute to diseases like cancer

Lena S1 Test

Lena S1 aims to enable pre-symptomatic and precise identification of lung cancer, providing a vital tool for improving survival rates and reducing diagnostic errors.

DNA Methylation in Early Lung Cancer Detection

Limitations of Traditional Methods and Lena S1's Solution

LENA Q51®

Innovative approach to leukemia diagnostics by targeting gene mutations, clonogenic gene rearrangements, and abnormal gene expression.

Fusion Genes as Key Biomarkers in Leukemia

LENA Q51's Breakthrough